Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting

View source ↗

Summary

An ongoing real-world clinical trial update evaluating the effectiveness and adverse events of Foscarbidopa/Foslevodopa in adults with advanced Parkinson diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Foscarbidopa/Foslevodopa (foscarbidopa; foslevodopa)

Snippet

Sponsor: AbbVie | Conditions: Advanced Parkinson Disease | Status: ACTIVE_NOT_RECRUITING